on May 22, 2017 University of Torino - Molecular Biotechnology Center will host the event: "Giornata di Studio Guido Tarone" with the following agenda:
10-10.50: Roberto Chiarle, “Mechanisms and modulation of genomic instability in lymphoma”, Harvard Medical School, Boston, USA.
10.50-11:10: Short talk, Danny Incarnato, “Principles of in vivo RNA folding”, Hugef, Torino, Italy.
11:10-11.30: Short talk, Sharmila Fagoonee, “Role of ESRP1 in colorectal cancer progression”, MBC, University of Torino, Torino, Italy.
11:30-12.20: Alberto Bardelli, “Cancer evolution as a therapeutic target”, IRCCS, University of Torino, Candiolo (TO), Italy.
13:30-14:20: Senthil Muthuswamy, “Cell Polarity and Organoids: New pathways and models for controlling cancer”, Harvard Medical School, Boston, USA.
14:20-14:40: Short talk, Paolo Ettore Porporato, “Mitochondrial metabolism on tumor progression and metastasis”, MBC, University of Torino, Torino, Italy.
14:40-15:00: Short talk, Miriam Martini, “PI3K-C2α is required for mitotic spindle assembly and genomic stability in breast cancer ”, MBC, University of Torino, Torino, Italy.
15:00-15:50: Pier Paolo Di Fiore, “Towards a stem cell-specific therapy of breast cancer”, IFOM, Milano, Italy.
15:50-16:10: Vincenzo Salemme, “p140Cap limits ERBB2 breast cancer progression and influences the tumor microenvironment”, MBC, University of Torino, Torino, Italy.
16:10-17:00: Alberto J. L. Macario, “The expanding field of chaperonopathies: a challenge for physicians and researchers in the biomedical sciences”, University of Maryland at Baltimore, Baltimore, USA.
17:00-17:50: Pier Paolo Pandolfi, “Ultra-Precision Medicine in Biomedical Research”, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, USA.
17:50-18:20: Closing remarks and “Premio Guido Tarone 2017” Award.
Attendance is free, but registration in advance is required.
Please register by 12th May 2017 sending an e-amil to firstname.lastname@example.org
For further details please contact: email@example.com or firstname.lastname@example.org